Report from the EASD Annual Meeting 2023 @EASDiabetes
Report from the EASD Annual Meeting 2023  @EASDiabetes
Uploaded February 2024 | Updated September 2026, 3 days ago
More than 8 billion people now live on earth and the alarming forecast is that by the year 2050 over 1.3 billion of them could become seriously ill. Diabetes is the number one widespread disease. Around 96% of those currently affected suffer from #type2diabetes, the form of disease that is mostly associated with being #overweight and according to research is largely preventable. The #type1diabetes disease which usually occurs in childhood also raises many questions.
An institution that has been successfully supporting and promoting the fight against #diabetes for many years is the @EASDiabetes, the European Association for the Study of Diabetes. For almost six decades it has brought together doctors, scientists, medical professionals and students in the fight against this devastating disease.
Groundbreaking research results and new therapies have become possible thanks to the EASD. We provide an important platform for knowledge exchange, #research #funding and #education. Our highly prestigious #awards support deserving medical professionals and scientists.
Report from the EASD Annual Meeting 2023EASD 2024 - Exercise is Medicine - Physical Activity and Insulin Action in DiabetesEASD 2023 - Miriam Cnop, Malin Fex and Timo Otonkoski on stem cell derived isletsEASD 2025: SURPASS-CVOT - A Comparison of Tirzepatide and Dulaglutide3rd EASD ECA Webinar: Tips & tricks to increase the chances of having your articles acceptedEASD 2024 - Will Next Generation Obesity Drugs make Bariatric Surgery Obsolete?EASD 2025: EASD - ESC Joint Symposium: Hot Topics in Diabetes and Cardiovascular DiseaseEASD 2024 - Breaking Barriers: Public-Private Partnerships Revolutionising Diabetes Research6th EASD Early Career Academy Webinar: Best of EASD#EASD2022  Interview with Helen Colhund  and Andrew Paterson on cardiovascular disease and T1DEASD 2023 - Andrew Frankel and Daniel van Raalte debating SGLT-2 inhibition for diabetes and CKDBest of EASD 2025 by the EASD Early Career Academy - featuring Dr. Eugenia Martin-Vazquez
European Association for the Study of Diabetes |

Report from the EASD Annual Meeting 2023

SHARE TO X SHARE TO REDDIT SHARE TO FACEBOOK WALLPAPER